{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:37:10Z","timestamp":1772051830276,"version":"3.50.1"},"publisher-location":"Cham","reference-count":97,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319501727","type":"print"},{"value":"9783319501741","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-50174-1_20","type":"book-chapter","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T13:44:03Z","timestamp":1489758243000},"page":"299-307","source":"Crossref","is-referenced-by-count":12,"title":["The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma"],"prefix":"10.1007","author":[{"given":"Barbara","family":"Mysona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Kansara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Bollinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,18]]},"reference":[{"issue":"11","key":"20_CR1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121(11):2081\u20132090","journal-title":"Ophthalmology"},{"issue":"3","key":"20_CR2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262\u2013267","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"20_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA et al (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):701\u2013713 discussion 829-30","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"20_CR4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A et al (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120(10):1268\u20131279","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"20_CR5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00055735-200304000-00006","volume":"14","author":"DR Anderson","year":"2003","unstructured":"Anderson DR (2003) Collaborative normal tension glaucoma study. Curr Opin Ophthalmol 14(2):86\u201390","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"20_CR6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","volume":"120","author":"MO Gordon","year":"2002","unstructured":"Gordon MO et al (2002) The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):714\u2013720 discussion 829-30","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"20_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","volume":"127","author":"L Nguyen","year":"2015","unstructured":"Nguyen L et al (2015) Role of sigma-1 receptors in neurodegenerative diseases. J Pharmacol Sci 127(1):17\u201329","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"20_CR8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12035-013-8416-8","volume":"48","author":"V Jindal","year":"2013","unstructured":"Jindal V (2013) Glaucoma: an extension of various chronic neurodegenerative disorders. Mol Neurobiol 48(1):186\u2013189","journal-title":"Mol Neurobiol"},{"issue":"11","key":"20_CR9","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1167\/iovs.08-2192","volume":"49","author":"Y He","year":"2008","unstructured":"He Y, Ge J, Tombran-Tink J (2008) Mitochondrial defects and dysfunction in calcium regulation in glaucomatous trabecular meshwork cells. Invest Ophthalmol Vis Sci 49(11):4912\u20134922","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"20_CR10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.molmed.2013.06.005","volume":"19","author":"RR Anholt","year":"2013","unstructured":"Anholt RR, Carbone MA (2013) A molecular mechanism for glaucoma: endoplasmic reticulum stress and the unfolded protein response. Trends Mol Med 19(10):586\u2013593","journal-title":"Trends Mol Med"},{"issue":"5","key":"20_CR11","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1167\/iovs.12-9483h","volume":"53","author":"RW Nickells","year":"2012","unstructured":"Nickells RW (2012) The cell and molecular biology of glaucoma: mechanisms of retinal ganglion cell death. Invest Ophthalmol Vis Sci 53(5):2476\u20132481","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"20_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2010.12.036","volume":"176","author":"SD Crish","year":"2011","unstructured":"Crish SD, Calkins DJ (2011) Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms. Neuroscience 176:1\u201311","journal-title":"Neuroscience"},{"issue":"2","key":"20_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/ICU.0000000000000125","volume":"26","author":"RS Chong","year":"2015","unstructured":"Chong RS, Martin KR (2015) Glial cell interactions and glaucoma. Curr Opin Ophthalmol 26(2):73\u201377","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"20_CR14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1083\/jcb.200706181","volume":"179","author":"GR Howell","year":"2007","unstructured":"Howell GR et al (2007) Axons of retinal ganglion cells are insulted in the optic nerve early in DBA\/2 J glaucoma. J Cell Biol 179(7):1523\u20131537","journal-title":"J Cell Biol"},{"issue":"6","key":"20_CR15","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1167\/iovs.03-1411","volume":"45","author":"B Fortune","year":"2004","unstructured":"Fortune B et al (2004) Selective ganglion cell functional loss in rats with experimental glaucoma. Invest Ophthalmol Vis Sci 45(6):1854\u20131862","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"20_CR16","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1167\/iovs.07-0483","volume":"48","author":"M Saleh","year":"2007","unstructured":"Saleh M, Nagaraju M, Porciatti V (2007) Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA\/2 J mouse model of glaucoma. Invest Ophthalmol Vis Sci 48(10):4564\u20134572","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"20_CR17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S0952523805225130","volume":"22","author":"RT Libby","year":"2005","unstructured":"Libby RT et al (2005) Inherited glaucoma in DBA\/2 J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci 22(5):637\u2013648","journal-title":"Vis Neurosci"},{"issue":"1","key":"20_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/glia.21242","volume":"60","author":"C Dai","year":"2012","unstructured":"Dai C et al (2012) Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure. Glia 60(1):13\u201328","journal-title":"Glia"},{"issue":"4","key":"20_CR19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cne.22516","volume":"519","author":"A Bosco","year":"2011","unstructured":"Bosco A, Steele MR, Vetter ML (2011) Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol 519(4):599\u2013620","journal-title":"J Comp Neurol"},{"issue":"3","key":"20_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1350-9462(99)00017-8","volume":"19","author":"MR Hernandez","year":"2000","unstructured":"Hernandez MR (2000) The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 19(3):297\u2013321","journal-title":"Prog Retin Eye Res"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exer.2016.01.014","volume":"150","author":"A Bosco","year":"2016","unstructured":"Bosco A et al (2016) Glial coverage in the optic nerve expands in proportion to optic axon loss in chronic mouse glaucoma. Exp Eye Res 150:34\u201343","journal-title":"Exp Eye Res"},{"issue":"1","key":"20_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.22058","volume":"516","author":"D Sun","year":"2009","unstructured":"Sun D et al (2009) The morphology and spatial arrangement of astrocytes in the optic nerve head of the mouse. J Comp Neurol 516(1):1\u201319","journal-title":"J Comp Neurol"},{"issue":"4","key":"20_CR23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","volume":"37","author":"TP Su","year":"2016","unstructured":"Su TP et al (2016) The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol Sci 37(4):262\u2013278","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"20_CR24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/jpet.103.051292","volume":"306","author":"T Hayashi","year":"2003","unstructured":"Hayashi T, Su TP (2003) Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells. J Pharmacol Exp Ther 306(2):726\u2013733","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"20_CR25","volume":"8","author":"T Mori","year":"2013","unstructured":"Mori T et al (2013) Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival. PLoS One 8(10):e76941","journal-title":"PLoS One"},{"key":"20_CR26","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1038\/srep10689","volume":"5","author":"TA Mavlyutov","year":"2015","unstructured":"Mavlyutov TA, Epstein M, Guo LW (2015) Subcellular localization of the sigma-1 receptor in retinal neurons \u2013 an electron microscopy study. Sci Rep 5:10689","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"20_CR27","first-page":"86","volume":"95","author":"MS Ola","year":"2001","unstructured":"Ola MS et al (2001) Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. Brain Res Mol Brain Res 95(1\u20132):86\u201395","journal-title":"Brain Res Mol Brain Res"},{"issue":"3","key":"20_CR28","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-3565(24)38280-1","volume":"289","author":"C Bucolo","year":"1999","unstructured":"Bucolo C et al (1999) Sigma1 recognition sites in rabbit iris-ciliary body: topical sigma1-site agonists lower intraocular pressure. J Pharmacol Exp Ther 289(3):1362\u20131369","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"20_CR29","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","volume":"131","author":"T Hayashi","year":"2007","unstructured":"Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131(3):596\u2013610","journal-title":"Cell"},{"issue":"1","key":"20_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1371\/journal.pgen.0010004","volume":"1","author":"RT Libby","year":"2005","unstructured":"Libby RT et al (2005) Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 1(1):17\u201326","journal-title":"PLoS Genet"},{"key":"20_CR31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2015.04.009","volume":"86","author":"J Wang","year":"2015","unstructured":"Wang J et al (2015) Sigma 1 receptor regulates the oxidative stress response in primary retinal Muller glial cells via NRF2 signaling and system xc(\u2212), the Na(+)-independent glutamate-cystine exchanger. Free Radic Biol Med 86:25\u201336","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"20_CR32","doi-asserted-by":"crossref","first-page":"e49384","DOI":"10.1371\/journal.pone.0049384","volume":"7","author":"XF Gao","year":"2012","unstructured":"Gao XF et al (2012) Sigma-1 receptor agonists directly inhibit Nav1.2\/1.4 channels. PLoS One 7(11):e49384","journal-title":"PLoS One"},{"issue":"5","key":"20_CR33","doi-asserted-by":"crossref","first-page":"C1049","DOI":"10.1152\/ajpcell.00431.2008","volume":"296","author":"M Johannessen","year":"2009","unstructured":"Johannessen M et al (2009) Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems. Am J Physiol Cell Physiol 296(5):C1049\u2013C1057","journal-title":"Am J Physiol Cell Physiol"},{"issue":"46","key":"20_CR34","doi-asserted-by":"crossref","first-page":"18219","DOI":"10.1523\/JNEUROSCI.3360-13.2013","volume":"33","author":"D Balasuriya","year":"2013","unstructured":"Balasuriya D, Stewart AP, Edwardson JM (2013) The sigma-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1\/GluN2A NMDA receptor. J Neurosci 33(46):18219\u201318224","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"20_CR35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2012.12.004","volume":"152","author":"S Kourrich","year":"2013","unstructured":"Kourrich S et al (2013) Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 152(1\u20132):236\u2013247","journal-title":"Cell"},{"key":"20_CR36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exer.2012.11.002","volume":"107","author":"BH Mueller 2nd","year":"2013","unstructured":"Mueller BH 2nd et al (2013) Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells. Exp Eye Res 107:21\u201331","journal-title":"Exp Eye Res"},{"issue":"8","key":"20_CR37","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.yexcr.2006.01.004","volume":"312","author":"L Wang","year":"2006","unstructured":"Wang L, Duncan G (2006) Silencing of sigma-1 receptor induces cell death in human lens cells. Exp Cell Res 312(8):1439\u20131446","journal-title":"Exp Cell Res"},{"issue":"1\u20132","key":"20_CR38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.molbrainres.2003.12.019","volume":"123","author":"PM Martin","year":"2004","unstructured":"Martin PM et al (2004) The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate. Brain Res Mol Brain Res 123(1\u20132):66\u201375","journal-title":"Brain Res Mol Brain Res"},{"issue":"9","key":"20_CR39","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1167\/iovs.08-1824","volume":"49","author":"SB Smith","year":"2008","unstructured":"Smith SB, J. D, Dun Y, Mysona B, Roon P, PM M, Ganapathy V (2008) In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. Invest Ophthalmol Vis Sci 49(9):4154\u20134161","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"20_CR40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exer.2014.10.007","volume":"128","author":"BH Mueller 2nd","year":"2014","unstructured":"Mueller BH 2nd et al (2014) Sigma-1 receptor stimulation protects retinal ganglion cells from ischemia-like insult through the activation of extracellular-signal-regulated kinases 1\/2. Exp Eye Res 128:156\u2013169","journal-title":"Exp Eye Res"},{"issue":"2","key":"20_CR41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1167\/iovs.15-18565","volume":"57","author":"J Zhao","year":"2016","unstructured":"Zhao J et al (2016) (+)-pentazocine reduces nmda-induced murine retinal ganglion cell death through a sigmar1-dependent mechanism. Invest Ophthalmol Vis Sci 57(2):453\u2013461","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"20_CR42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/syn.21549","volume":"66","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M et al (2012) Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor. Synapse 66(7):630\u2013639","journal-title":"Synapse"},{"issue":"10","key":"20_CR43","volume":"8","author":"Y Kimura","year":"2013","unstructured":"Kimura Y et al (2013) Sigma-1 receptor enhances neurite elongation of cerebellar granule neurons via TrkB signaling. PLoS One 8(10):e75760","journal-title":"PLoS One"},{"issue":"Pt 7","key":"20_CR44","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/brain\/awu107","volume":"137","author":"V Francardo","year":"2014","unstructured":"Francardo V et al (2014) Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. Brain 137(Pt 7):1998\u20132014","journal-title":"Brain"},{"issue":"28","key":"20_CR45","doi-asserted-by":"crossref","first-page":"19646","DOI":"10.1074\/jbc.M802192200","volume":"283","author":"A Pal","year":"2008","unstructured":"Pal A et al (2008) Juxtaposition of the steroid binding domain-like I and II regions constitutes a ligand binding site in the sigma-1 receptor. J Biol Chem 283(28):19646\u201319656","journal-title":"J Biol Chem"},{"issue":"7","key":"20_CR46","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2174\/138161212799436584","volume":"18","author":"AE Ruoho","year":"2012","unstructured":"Ruoho AE et al (2012) The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines. Curr Pharm Des 18(7):920\u2013929","journal-title":"Curr Pharm Des"},{"issue":"2\u20133","key":"20_CR47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2007.09.020","volume":"578","author":"IT Lee","year":"2008","unstructured":"Lee IT, Chen S, Schetz JA (2008) An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones. Eur J Pharmacol 578(2\u20133):123\u2013136","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"20_CR48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0922-4106(94)90102-3","volume":"266","author":"A Cagnotto","year":"1994","unstructured":"Cagnotto A, Bastone A, Mennini T (1994) [3H](+)-pentazocine binding to rat brain sigma 1 receptors. Eur J Pharmacol 266(2):131\u2013138","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"20_CR49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00023210-200418050-00001","volume":"18","author":"T Hayashi","year":"2004","unstructured":"Hayashi T, Su TP (2004) Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs 18(5):269\u2013284","journal-title":"CNS Drugs"},{"issue":"2","key":"20_CR50","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3565(25)20283-X","volume":"259","author":"TP Su","year":"1991","unstructured":"Su TP et al (1991) Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. J Pharmacol Exp Ther 259(2):543\u2013550","journal-title":"J Pharmacol Exp Ther"},{"issue":"18","key":"20_CR51","doi-asserted-by":"crossref","first-page":"PL285-90","DOI":"10.1016\/0024-3205(93)90588-T","volume":"53","author":"S Okuyama","year":"1993","unstructured":"Okuyama S et al (1993) NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci 53(18):PL285-90","journal-title":"Life Sci"},{"issue":"3","key":"20_CR52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","volume":"280","author":"RR Matsumoto","year":"1995","unstructured":"Matsumoto RR et al (1995) Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol 280(3):301\u2013310","journal-title":"Eur J Pharmacol"},{"issue":"23","key":"20_CR53","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.1158\/0008-5472.CAN-07-1771","volume":"67","author":"CP Palmer","year":"2007","unstructured":"Palmer CP et al (2007) Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res 67(23):11166\u201311175","journal-title":"Cancer Res"},{"issue":"5916","key":"20_CR54","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","volume":"323","author":"D Fontanilla","year":"2009","unstructured":"Fontanilla D et al (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323(5916):934\u2013937","journal-title":"Science"},{"key":"20_CR55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2202-7-66","volume":"7","author":"CL Schlamp","year":"2006","unstructured":"Schlamp CL et al (2006) Progressive ganglion cell loss and optic nerve degeneration in DBA\/2 J mice is variable and asymmetric. BMC Neurosci 7:66","journal-title":"BMC Neurosci"},{"issue":"4","key":"20_CR56","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.neuroscience.2010.03.006","volume":"167","author":"LL Liu","year":"2010","unstructured":"Liu LL et al (2010) Expression of sigma receptor 1 mRNA and protein in rat retina. Neuroscience 167(4):1151\u20131159","journal-title":"Neuroscience"},{"key":"20_CR57","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/jcp.25305","volume":"231","author":"SC Sacca","year":"2016","unstructured":"Sacca SC et al (2016) The outflow pathway: a tissue with morphological and functional unity. J Cell Physiol 231:1876\u20131893","journal-title":"J Cell Physiol"},{"issue":"6703","key":"20_CR58","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/27094","volume":"395","author":"MJ Berridge","year":"1998","unstructured":"Berridge MJ, Bootman MD, Lipp P (1998) Calcium \u2013 a life and death signal. Nature 395(6703):645\u2013648","journal-title":"Nature"},{"issue":"11","key":"20_CR59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrn1788","volume":"6","author":"M Coleman","year":"2005","unstructured":"Coleman M (2005) Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 6(11):889\u2013898","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"20_CR60","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.preteyeres.2012.07.001","volume":"31","author":"DJ Calkins","year":"2012","unstructured":"Calkins DJ (2012) Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog Retin Eye Res 31(6):702\u2013719","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"20_CR61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12035-010-8128-2","volume":"42","author":"S Brady","year":"2010","unstructured":"Brady S, Morfini G (2010) A perspective on neuronal cell death signaling and neurodegeneration. Mol Neurobiol 42(1):25\u201331","journal-title":"Mol Neurobiol"},{"issue":"2","key":"20_CR62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1254\/jjp.74.125","volume":"74","author":"Y Yoshida","year":"1997","unstructured":"Yoshida Y, Imai S (1997) Structure and function of inositol 1,4,5-trisphosphate receptor. Jpn J Pharmacol 74(2):125\u2013137","journal-title":"Jpn J Pharmacol"},{"issue":"2","key":"20_CR63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","volume":"124","author":"T Maurice","year":"2009","unstructured":"Maurice T, Su TP (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124(2):195\u2013206","journal-title":"Pharmacol Ther"},{"issue":"6","key":"20_CR64","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1152\/jn.2002.87.6.2867","volume":"87","author":"H Zhang","year":"2002","unstructured":"Zhang H, Cuevas J (2002) Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87(6):2867\u20132879","journal-title":"J Neurophysiol"},{"issue":"11","key":"20_CR65","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1167\/iovs.08-1867","volume":"49","author":"KT Tchedre","year":"2008","unstructured":"Tchedre KT et al (2008) Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. Invest Ophthalmol Vis Sci 49(11):4993\u20135002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"20_CR66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1124\/mol.109.062539","volume":"77","author":"T Hayashi","year":"2010","unstructured":"Hayashi T, Fujimoto M (2010) Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction. Mol Pharmacol 77(4):517\u2013528","journal-title":"Mol Pharmacol"},{"issue":"1","key":"20_CR67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1167\/iovs.10-5731","volume":"52","author":"Y Ha","year":"2011","unstructured":"Ha Y et al (2011) Sigma receptor 1 modulates endoplasmic reticulum stress in retinal neurons. Invest Ophthalmol Vis Sci 52(1):527\u2013540","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"20_CR68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00441-013-1774-8","volume":"356","author":"Y Ha","year":"2014","unstructured":"Ha Y et al (2014) Sigma receptor 1 modulates ER stress and Bcl2 in murine retina. Cell Tissue Res 356(1):15\u201327","journal-title":"Cell Tissue Res"},{"issue":"1\u20133","key":"20_CR69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2012.01.030","volume":"682","author":"A Pal","year":"2012","unstructured":"Pal A et al (2012) The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. Eur J Pharmacol 682(1\u20133):12\u201320","journal-title":"Eur J Pharmacol"},{"issue":"11\u201312","key":"20_CR70","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.mad.2012.09.005","volume":"133","author":"L Wang","year":"2012","unstructured":"Wang L et al (2012) Sigma 1 receptor stimulation protects against oxidative damage through suppression of the ER stress responses in the human lens. Mech Ageing Dev 133(11\u201312):665\u2013674","journal-title":"Mech Ageing Dev"},{"issue":"3","key":"20_CR71","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.wnr.0000199469.21734.e1","volume":"17","author":"C Bucolo","year":"2006","unstructured":"Bucolo C et al (2006) Sigma receptor ligands protect human retinal cells against oxidative stress. Neuroreport 17(3):287\u2013291","journal-title":"Neuroreport"},{"issue":"8","key":"20_CR72","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrc3278","volume":"12","author":"MB Sporn","year":"2012","unstructured":"Sporn MB, Liby KT (2012) NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 12(8):564\u2013571","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"20_CR73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1389557516666151120114605","volume":"16","author":"J Kruk","year":"2015","unstructured":"Kruk J, Kubasik-Kladna K, Aboul-Enein HY (2015) The role oxidative stress in the pathogenesis of eye diseases: current status and a dual role of physical activity. Mini-Rev Med Chem 16(3):241\u2013257","journal-title":"Mini-Rev Med Chem"},{"key":"20_CR74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.pbr.2015.06.001","volume":"220","author":"MD Pinazo-Duran","year":"2015","unstructured":"Pinazo-Duran MD et al (2015) Oxidative stress and mitochondrial failure in the pathogenesis of glaucoma neurodegeneration. Prog Brain Res 220:127\u2013153","journal-title":"Prog Brain Res"},{"issue":"4","key":"20_CR75","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.survophthal.2015.01.004","volume":"60","author":"LP Doucette","year":"2015","unstructured":"Doucette LP et al (2015) The interactions of genes, age, and environment in glaucoma pathogenesis. Surv Ophthalmol 60(4):310\u2013326","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"20_CR76","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1167\/iovs.07-0343","volume":"48","author":"Y Dun","year":"2007","unstructured":"Dun Y et al (2007) Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand. Invest Ophthalmol Vis Sci 48(10):4785\u20134794","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"20_CR77","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1167\/iovs.08-1824","volume":"49","author":"SB Smith","year":"2008","unstructured":"Smith SB et al (2008) In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. Invest Ophthalmol Vis Sci 49(9):4154\u20134161","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"20_CR78","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/jpet.109.160960","volume":"332","author":"J Meunier","year":"2010","unstructured":"Meunier J, Hayashi T (2010) Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB. J Pharmacol Exp Ther 332(2):388\u2013397","journal-title":"J Pharmacol Exp Ther"},{"issue":"6521","key":"20_CR79","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/374450a0","volume":"374","author":"A Acheson","year":"1995","unstructured":"Acheson A et al (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374(6521):450\u2013453","journal-title":"Nature"},{"key":"20_CR80","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"20_CR81","first-page":"764","volume":"41","author":"ME Pease","year":"2000","unstructured":"Pease ME et al (2000) Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 41(3):764\u2013774","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"20_CR82","first-page":"3460","volume":"41","author":"HA Quigley","year":"2000","unstructured":"Quigley HA et al (2000) Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci 41(11):3460\u20133466","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"20_CR83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2008.05.055","volume":"440","author":"K Kikuchi-Utsumi","year":"2008","unstructured":"Kikuchi-Utsumi K, Nakaki T (2008) Chronic treatment with a selective ligand for the sigma-1 receptor chaperone, SA4503, up-regulates BDNF protein levels in the rat hippocampus. Neurosci Lett 440(1):19\u201322","journal-title":"Neurosci Lett"},{"issue":"10","key":"20_CR84","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1111\/bph.13076","volume":"172","author":"M Malik","year":"2015","unstructured":"Malik M et al (2015) The effects of sigma (sigma1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice. Br J Pharmacol 172(10):2519\u20132531","journal-title":"Br J Pharmacol"},{"issue":"6","key":"20_CR85","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1167\/iovs.13-12823","volume":"55","author":"J Zhao","year":"2014","unstructured":"Zhao J et al (2014) Sigma receptor ligand, (+)-pentazocine, suppresses inflammatory responses of retinal microglia. Invest Ophthalmol Vis Sci 55(6):3375\u20133384","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"20_CR86","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/glia.20802","volume":"57","author":"AA Hall","year":"2009","unstructured":"Hall AA, Y. H, CT A Jr, Cuevas J, KR P (2009) Sigma receptors suppress multiple aspects of microglial activation. Glia 57(7):744\u2013754","journal-title":"Glia"},{"issue":"5","key":"20_CR87","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jnc.13002","volume":"132","author":"A Shanmugam","year":"2014","unstructured":"Shanmugam A et al (2014) Sigma receptor 1 activation attenuates release of inflammatory cytokines MIP1gamma, MIP2, MIP3alpha, and IL12 (p40\/p70) by retinal Muller glial cells. J Neurochem 132(5):546\u2013558","journal-title":"J Neurochem"},{"issue":"3","key":"20_CR88","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1124\/jpet.102.040584","volume":"303","author":"G Campana","year":"2002","unstructured":"Campana G et al (2002) Ocular hypotensive action of topical flunarizine in the rabbit: role of sigma 1 recognition sites. J Pharmacol Exp Ther 303(3):1086\u20131094","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"20_CR89","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1007\/s11033-012-1491-5","volume":"39","author":"X Sun","year":"2012","unstructured":"Sun X et al (2012) Pregnenolone sulfate decreases intraocular pressure and changes expression of sigma receptor in a model of chronic ocular hypertension. Mol Biol Rep 39(6):6607\u20136614","journal-title":"Mol Biol Rep"},{"issue":"10","key":"20_CR90","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1167\/iovs.11-8169","volume":"52","author":"Y Ha","year":"2011","unstructured":"Ha Y, Saul A, Tawfik A, Williams C, Bollinger K, Smith R, Tachikawa M, Zorrilla E, Ganapathy V, SB S (2011) Late-onset inner retinal dysfunction in mice lacking sigma receptor 1 (\u03c3R1). Invest Ophthalmol Vis Sci 52(10):7749\u20137760","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"20_CR91","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1161\/STROKEAHA.114.005835","volume":"45","author":"R Urfer","year":"2014","unstructured":"Urfer R et al (2014) Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke. Stroke 45(11):3304\u20133310","journal-title":"Stroke"},{"issue":"21","key":"20_CR92","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.4103\/1673-5374.145351","volume":"9","author":"V Francardo","year":"2014","unstructured":"Francardo V (2014) Sigma-1 receptor: a potential new target for Parkinson\u2019s disease? Neural Regen Res 9(21):1882\u20131883","journal-title":"Neural Regen Res"},{"key":"20_CR93","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.170","volume":"4","author":"A Hyrskyluoto","year":"2013","unstructured":"Hyrskyluoto A et al (2013) Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-kappaB pathway. Cell Death Dis 4:e646","journal-title":"Cell Death Dis"},{"issue":"19","key":"20_CR94","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1073\/pnas.1300677110","volume":"110","author":"L Hedskog","year":"2013","unstructured":"Hedskog L et al (2013) Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer\u2019s disease and related models. Proc Natl Acad Sci U S A 110(19):7916\u20137921","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 3","key":"20_CR95","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/brain\/awq367","volume":"134","author":"K Ruscher","year":"2011","unstructured":"Ruscher K et al (2011) The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain 134(Pt 3):732\u2013746","journal-title":"Brain"},{"issue":"5","key":"20_CR96","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1471-4159.2011.07256.x","volume":"117","author":"S Moriguchi","year":"2011","unstructured":"Moriguchi S et al (2011) Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice. J Neurochem 117(5):879\u2013891","journal-title":"J Neurochem"},{"issue":"2","key":"20_CR97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0169-328X(02)00444-8","volume":"107","author":"MS Ola","year":"2002","unstructured":"Ola MS et al (2002) Analysis of sigma receptor (sigmaR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice. Brain Res Mol Brain Res 107(2):97\u2013107","journal-title":"Brain Res Mol Brain Res"}],"container-title":["Advances in Experimental Medicine and Biology","Sigma Receptors: Their Role in Disease and as Therapeutic Targets"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-50174-1_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T01:07:47Z","timestamp":1750122467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-50174-1_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319501727","9783319501741"],"references-count":97,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-50174-1_20","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}